Skip to Content
Merck
All Photos(1)

Key Documents

257583

Sigma-Aldrich

8-Bromooctanoic acid

97%

Synonym(s):

8-Bromocaprylic acid

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
Br(CH2)7CO2H
CAS Number:
Molecular Weight:
223.11
Beilstein:
1756103
MDL number:
UNSPSC Code:
12352106
PubChem Substance ID:
NACRES:
NA.22

Quality Level

Assay

97%

reaction suitability

reagent type: cross-linking reagent

bp

147-150 °C/2 mmHg (lit.)

mp

35-37 °C (lit.)

functional group

bromo
carboxylic acid

SMILES string

OC(CCCCCCCBr)=O

InChI

1S/C8H15BrO2/c9-7-5-3-1-2-4-6-8(10)11/h1-7H2,(H,10,11)

InChI key

BKJFDZSBZWHRNH-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

8-Bromooctanoic acid, also known as 8-bromocaprylic acid, is a cross-linking reagent. It can undergo hydrolysis to form 8-hydroxyoctanoic acid.

Application

8-Bromooctanoic acid can be used as a crosslinking reagent to:
  • prepare 8-mercaptooctanoic acid in the biosynthesis of lipoic acid
  • attach triple helix-forming oligonucleotides (TFOs) to inhibitors in their synthesis

Pictograms

Corrosion

Signal Word

Danger

Hazard Statements

Hazard Classifications

Eye Dam. 1 - Skin Corr. 1B

Storage Class Code

8A - Combustible corrosive hazardous materials

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Soumen Das et al.
Journal of labelled compounds & radiopharmaceuticals, 61(14), 1048-1057 (2018-09-02)
123 I-Iodophenylpentadecanoic acid (IPPA) is a metabolic agent used in nuclear medicine for diagnosis of myocardial defects. Efforts are underway worldwide to develop a 99m Tc substitute of the above radiopharmaceutical for the aforementioned application. Herein, we report synthesis and
Beibei Hou et al.
Materials science & engineering. C, Materials for biological applications, 74, 94-102 (2017-03-04)
How to encapsulate and transport the payload of multiple therapeutic compounds avoiding premature leakage, and simultaneously co-release them rapidly at specific lesions still remains the major concern in clinic. Herein, we designed the UCN@mSiO

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service